The Office of the Commissioner of Baseball announced today that Arizona Diamondbacks infielder Domingo Leyba has received an 80-game suspension without pay after testing positive for Boldenone, a performance-enhancing substance, in violation of Major League Baseball’s Joint Drug Prevention and Treatment Program.

The suspension of Leyba will commence at the start of the 2020 regular season.

The D-backs released the following statement:

“We support MLB’s Joint Drug Agreement and the penalties for violating that policy. We were disappointed to learn of this news and hope that Domingo will take the time away from the game to reflect on his actions and learn from his mistakes.”